Association Between Persistence with Oral Atypical Antipsychotic Medications and Hospital and Emergency Department Utilization in Medicaid Patients with Schizophrenia
Article in Patient Preference and Adherence (January 2024)
The most recent citing publications are shown below. View all 35 publications that cite this research output on Dimensions.
Post Hospitalization Clinical Quality Outcomes Among US Patients with Schizophrenia Treated with a Long-Acting Injectable or Switched to a New Oral Antipsychotic: A Retrospective Cohort Study
Article in Drugs - Real World Outcomes (December 2023)
Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria
Article in The Lancet Psychiatry (November 2023)